Nova Ltd.
NVMI NASDAQTechnology ★★★★★Latest Earnings
Date
Aug 6, 2026
ET
EPS Est.
2.41
EPS Actual
2.51
Revenue Est.
$250.3M
Revenue Actual
$255M
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
2.75
Revenue Est.
$282.1M
Company Overview
Nova Ltd. (ticker NVMI) is listed on NASDAQ with a market cap of about $11.98B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Pre-market, with consensus EPS of 2.75. In the last 15 reported quarters, EPS beat consensus estimates 15 times.
Actual EPS TrendRecently15Term · Feb 15, 2023 → Aug 6, 2026
Feb 15, 2023Range: 1.06 ~ 2.51Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | 2.41 | 2.51 | $250.3M | $255M |
| May 14, 2026 | -- | 2.19 | 2.33 | $227M | $235.3M |
| Feb 12, 2026 | -- | 2.13 | 2.14 | $220.9M | $222.6M |
| Nov 6, 2025 | -- | 2.15 | 2.16 | $222.2M | $224.6M |
| Aug 7, 2025 | -- | 2.05 | 2.20 | $217.3M | $220M |
| May 8, 2025 | -- | 2.08 | 2.18 | $210.6M | $213.4M |
| Feb 13, 2025 | -- | 1.82 | 1.94 | $198.1M | $194.8M |
| Nov 7, 2024 | -- | 1.68 | 1.74 | $171.8M | $179M |
| Aug 8, 2024 | -- | 1.36 | Above forecast↑1.61 | $148.1M | $156.9M |
| May 9, 2024 | -- | 1.27 | 1.39 | $136.8M | $141.8M |
| Feb 15, 2024 | -- | 1.24 | 1.36 | $128M | $134.2M |
| Nov 9, 2023 | -- | 1.09 | 1.23 | $123.1M | $128.8M |
| Aug 3, 2023 | -- | 1.00 | 1.06 | $121.7M | $122.7M |
| May 11, 2023 | -- | 1.05 | Above forecast↑1.23 | $130.1M | $132.2M |
| Feb 15, 2023 | -- | 1.25 | 1.28 | $147.8M | $151.2M |
Original Filings (SEC)
6-K2026-08-11 ↗
6-K2026-08-06 ↗
6-K2026-07-06 ↗
6-K2026-07-02 ↗
6-K2026-06-22 ↗
6-K2026-05-18 ↗
6-K2026-05-14 ↗
6-K2026-05-14 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
